Elanco Animal Health Incorporated (NYSE:ELAN) captured analyst attention after its recent Investor Day presentation, where it outlined a three-year strategic roadmap. Trading at $19.86 with a market cap of $9.92 billion, the stock has delivered a 53.72% return over the past year, though recent volatility saw shares decline from $21.64.
The pet health division is the faster-growing segment, with high-single-digit growth projected through FY2028. The farm animal segment faces a mature market with low- to mid-single-digit growth. Analysts view the company's conservative targets as potentially creating room for positive surprises.
